Category: Pharma News
Urgent Alert: Safety Concerns Surrounding Meftal Spas – The Dangers of Mefenamic Acid Revealed
If you rely on Meftal Spas to alleviate pain, menstrual cramps, or manage rheumatoid arthritis, this news is…
DCC Explores Measures to Address Potential Misuse of Tapentadol and Pregabalin: Regulatory Insights and Recommendations
The Drugs Consultative Committee (DCC) has recently undertaken a comprehensive examination into the potential misuse of opioid pain-relief…
Opposition Grows Against Proposed NPC Bill 2023: Pharmacy Students Advocate for the Retention of Pharmacy Council of India (PCI)
In a recent development, the Union health ministry's draft National Pharmacy Commission (NPC) Bill 2023 faces opposition from…
Unmasking Fake Pharmacists: FSDCA Rajasthan Exposes 101 Sham Registrations
The Food Safety and Drug Control Administration (FSDCA) in Rajasthan has unearthed a shocking revelation, exposing 101 fraudulent…
Ensuring Global Standards: DCC Urged all States to Submit Vaccine Data for WHO Benchmarking
In a significant move towards global vaccine quality benchmarks, the Drugs Consultative Committee (DCC) has called upon all…
DCC Proposes QR Code Amendment for Comprehensive Drug Information
In a significant move aimed at enhancing patient safety and awareness, the Drugs Consultative Committee (DCC) under the…
Addressing Quality Concerns: DCC Urges Strict Adherence to Pharma-Grade Excipients in Drug Manufacturing
In a decisive move to tackle quality issues in pharmaceutical excipients, the Drugs Consultative Committee (DCC) of the…
Navigating Healthcare Growth: The Crucial Role of Medical Representatives
In the dynamic landscape of healthcare, medical representatives serve as vital bridges between pharmaceutical companies and healthcare professionals.…
Empowering Ayurveda: CCRAS Launches ‘Ayurveda Gyan Naipunya Initiative’ (AGNI) to Elevate Evidence-Based Practices
In a groundbreaking move towards promoting research and validating pragmatic Ayurveda practices, the Central Council for Research in…
CDSCO Reveals 5.5% of Drug Samples Not Meeting Standards in October 2023
In a recent revelation by the Central Drugs Standard Control Organisation (CDSCO), nearly 5.5% of drug samples tested…
